Boston Micro Fabrication - BMF’s Post

IMcoMET, a startup in the medical sector focusing on skin cancer, uses microneedles to extract interstitial fluid for cancer biomarkers analysis. Traditionally, these tests are invasive and cumbersome, often requiring multiple attempts to collect a sufficient amount of fluid. However, with BMF's PµSL #microprinting technology, IMcoMET was able to create a more efficient microneedle design, enabling more effective, personalized care and is set to transform how biomarkers are collected and analyzed, demonstrating BMF’s critical role in advancing #medicaltechnology. Founder and CTO, Alexandre Motta, says, “Boston Micro Fabrication’s technology is ideal for the precision and resolution we want to achieve, where the SLA process cannot. It’s also much more affordable than nanoimprinting and enables rapid scale-up. It’s an excellent choice for IMcoMET and we’re already developing other projects with the BMF teams.” Read the full article in 3Dnatives: https://lnkd.in/gxpn_GUi!

IMcoMET Fights Skin Cancer With Micro 3D Printing - 3Dnatives

IMcoMET Fights Skin Cancer With Micro 3D Printing - 3Dnatives

3dnatives.com

Thanks for sharing! It's a great example of how micro #3dprinting can revolutionize sectors like #healthcare

Like
Reply

To view or add a comment, sign in

Explore topics